These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 22786786)
1. Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy: a pooled analysis of 6 prospective trials. Bauer TM; El-Rayes BF; Li X; Hammad N; Philip PA; Shields AF; Zalupski MM; Bekaii-Saab T Cancer; 2013 Jan; 119(2):285-92. PubMed ID: 22786786 [TBL] [Abstract][Full Text] [Related]
3. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421 [TBL] [Abstract][Full Text] [Related]
4. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling. Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689 [TBL] [Abstract][Full Text] [Related]
5. Anti-angiogenic therapy for high-grade glioma. Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
7. [A real-world study of first-line albumin-bound paclitaxel in the treatment of advanced pancreatic cancer in China]. Du J; Qiu X; Ni JY; Wang QL; Tong F; Sha HZ; Zhu YH; Qi L; Cai W; Gao C; Wei XW; Chen MB; Qian ZY; Cai MH; Tao M; Wang CL; Zheng GC; Jiang H; Dai AW; Wu J; Zhao MH; Li XQ; Lu B; Wang CB; Liu BR Zhonghua Zhong Liu Za Zhi; 2024 Nov; 46(11):1038-1048. PubMed ID: 39622736 [No Abstract] [Full Text] [Related]
8. The prognostic value of CA19-9 response after neoadjuvant therapy in patients with pancreatic cancer: a systematic review and pooled analysis. Ye C; Sadula A; Ren S; Guo X; Yuan M; Yuan C; Xiu D Cancer Chemother Pharmacol; 2020 Dec; 86(6):731-740. PubMed ID: 33047181 [TBL] [Abstract][Full Text] [Related]
9. Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis. Curry N; Davenport R; Thomas H; Fox E; Lucas J; Evans A; Massou E; Sharma R; Shanmugaranjan S; Rourke C; Newton A; Deary A; Dallas N; Fitzpatrick-Creamer C; Podbielski JM; Wade CE; Edwards A; Benger J; Morris S; Cotton BA; Piercy J; Green L; Brohi K; Stanworth S Health Technol Assess; 2024 Nov; 28(76):1-69. PubMed ID: 39545850 [TBL] [Abstract][Full Text] [Related]
10. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early-stage Hodgkin's lymphoma. Goldkuhle M; Kreuzberger N; von Tresckow B; Eichenauer DA; Specht L; Monsef I; Skoetz N Cochrane Database Syst Rev; 2024 Dec; 12(12):CD007110. PubMed ID: 39620432 [TBL] [Abstract][Full Text] [Related]
11. Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis. Mastrantoni L; Chiaravalli M; Spring A; Beccia V; Di Bello A; Bagalà C; Bensi M; Barone D; Trovato G; Caira G; Giordano G; Bria E; Tortora G; Salvatore L Lancet Oncol; 2024 Dec; 25(12):1655-1665. PubMed ID: 39542008 [TBL] [Abstract][Full Text] [Related]
12. Does the SORG Machine-learning Algorithm for Extremity Metastases Generalize to a Contemporary Cohort of Patients? Temporal Validation From 2016 to 2020. de Groot TM; Ramsey D; Groot OQ; Fourman M; Karhade AV; Twining PK; Berner EA; Fenn BP; Collins AK; Raskin K; Lozano S; Newman E; Ferrone M; Doornberg JN; Schwab JH Clin Orthop Relat Res; 2023 Dec; 481(12):2419-2430. PubMed ID: 37229565 [TBL] [Abstract][Full Text] [Related]
13. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
14. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE. Robertson L; Yeoh SE; Stansby G; Agarwal R Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010837. PubMed ID: 28832905 [TBL] [Abstract][Full Text] [Related]
15. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE. Robertson L; Yeoh SE; Broderick C; Stansby G; Agarwal R Cochrane Database Syst Rev; 2018 Nov; 11(11):CD010837. PubMed ID: 30407621 [TBL] [Abstract][Full Text] [Related]
16. Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial. Morgan RD; McNeish IA; Cook AD; James EC; Lord R; Dark G; Glasspool RM; Krell J; Parkinson C; Poole CJ; Hall M; Gallardo-Rincón D; Lockley M; Essapen S; Summers J; Anand A; Zachariah A; Williams S; Jones R; Scatchard K; Walther A; Kim JW; Sundar S; Jayson GC; Ledermann JA; Clamp AR Lancet Oncol; 2021 Feb; 22(2):277-288. PubMed ID: 33357510 [TBL] [Abstract][Full Text] [Related]
17. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE. Robertson L; Broderick C; Yeoh SE; Stansby G Cochrane Database Syst Rev; 2021 Oct; 10(10):CD010837. PubMed ID: 34597414 [TBL] [Abstract][Full Text] [Related]
18. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]